2-methyl-6-(4-methoxyphenyl)-3-7-dihydroimidazo(1-2-alpha)pyrazin-3-one and Neoplasms

2-methyl-6-(4-methoxyphenyl)-3-7-dihydroimidazo(1-2-alpha)pyrazin-3-one has been researched along with Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for 2-methyl-6-(4-methoxyphenyl)-3-7-dihydroimidazo(1-2-alpha)pyrazin-3-one and Neoplasms

ArticleYear
A Patient-Derived Organoid Screen Identified the Bispecific Antibody MCLA-158.
    Cancer discovery, 2022, 07-06, Volume: 12, Issue:7

    MCLA-158, an LGR5 × EGFR bispecific antibody, inhibits growth and metastasis of colorectal cancer.

    Topics: Antibodies, Bispecific; Cell Proliferation; Humans; Imidazoles; Neoplasms; Organoids; Pyrazines

2022